213 related articles for article (PubMed ID: 9848817)
1. Evaluating the use of angiotensin-converting enzyme inhibitors for older nursing home residents with chronic heart failure.
Forman DE; Chander RB; Lapane KL; Shah P; Stoukides J
J Am Geriatr Soc; 1998 Dec; 46(12):1550-4. PubMed ID: 9848817
[TBL] [Abstract][Full Text] [Related]
2. Interaction between aspirin and angiotensin-converting enzyme inhibitors: should they be used together in older adults with heart failure?
Ahmed A
J Am Geriatr Soc; 2002 Jul; 50(7):1293-6. PubMed ID: 12133028
[TBL] [Abstract][Full Text] [Related]
3. Patterns of pharmacologic treatment of congestive heart failure in elderly nursing home residents and related issues: a review of the literature.
Litaker JR; Chou JY
Clin Ther; 2003 Jul; 25(7):1918-35. PubMed ID: 12946542
[TBL] [Abstract][Full Text] [Related]
4. Neurohormonal activation and congestive heart failure: today's experience with ACE inhibitors and rationale for their use.
Sigurdsson A; Swedberg K
Eur Heart J; 1995 Dec; 16 Suppl N():65-72. PubMed ID: 8682064
[TBL] [Abstract][Full Text] [Related]
5. Determinants of angiotensin-converting enzyme inhibitor prescription in severe heart failure with left ventricular systolic dysfunction: the EPICAL study.
Echemann M; Zannad F; Briançon S; Juillière Y; Mertès PM; Virion JM; Villemot JP
Am Heart J; 2000 Apr; 139(4):624-31. PubMed ID: 10740143
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
7. Systolic versus diastolic heart failure in community practice: clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors.
Philbin EF; Rocco TA; Lindenmuth NW; Ulrich K; Jenkins PL
Am J Med; 2000 Dec; 109(8):605-13. PubMed ID: 11099679
[TBL] [Abstract][Full Text] [Related]
8. Management of heart failure in Canadian long-term care facilities.
Heckman GA; Misiaszek B; Merali F; Turpie ID; Patterson CJ; Flett N; McKelvie RS
Can J Cardiol; 2004 Aug; 20(10):963-9. PubMed ID: 15332144
[TBL] [Abstract][Full Text] [Related]
9. Drug treatment of heart failure--do nursing-home residents deserve better?
Ruths S; Straand J; Nygaard HA; Hodneland F
Scand J Prim Health Care; 2000 Dec; 18(4):226-31. PubMed ID: 11205091
[TBL] [Abstract][Full Text] [Related]
10. National patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction.
Masoudi FA; Rathore SS; Wang Y; Havranek EP; Curtis JP; Foody JM; Krumholz HM
Circulation; 2004 Aug; 110(6):724-31. PubMed ID: 15289383
[TBL] [Abstract][Full Text] [Related]
11. ACE inhibitors in heart failure: what more do we need to know?
Demers C; Mody A; Teo KK; McKelvie RS
Am J Cardiovasc Drugs; 2005; 5(6):351-9. PubMed ID: 16259523
[TBL] [Abstract][Full Text] [Related]
12. Patterns of angiotensin-converting enzyme inhibitor prescriptions, educational interventions, and outcomes among hospitalized patients with heart failure.
McDermott MM; Lee P; Mehta S; Gheorghiade M
Clin Cardiol; 1998 Apr; 21(4):261-8. PubMed ID: 9562936
[TBL] [Abstract][Full Text] [Related]
13. Does aspirin attenuate the effect of angiotensin-converting enzyme inhibitors on health outcomes of very old patients with heart failure?
Lapane KL; Hume AL; Barbour MM; Lipsitz LA
J Am Geriatr Soc; 2002 Jul; 50(7):1198-204. PubMed ID: 12133013
[TBL] [Abstract][Full Text] [Related]
14. Experience with beta-blocker therapy in patients with advanced heart failure evaluated for HTx.
Berger R; Strecker K; Hülsmann M; Frey B; Pacher R; Stanek B
J Heart Lung Transplant; 2000 Nov; 19(11):1081-8. PubMed ID: 11077226
[TBL] [Abstract][Full Text] [Related]
15. Lisinopril and captopril in the treatment of heart failure in older patients. Comparison of a long- and short-acting angiotensin-converting enzyme inhibitor.
Giles TD; Fisher MB; Rush JE
Am J Med; 1988 Sep; 85(3B):44-7. PubMed ID: 2844087
[TBL] [Abstract][Full Text] [Related]
16. ACE-inhibitor therapy at relatively high doses and risk of renal worsening in chronic heart failure.
De Vecchis R; Di Biase G; Ariano C; Cioppa C; Giasi A; Ciccarelli A; Pucciarelli A; Cantatrione S
Arq Bras Cardiol; 2011 Dec; 97(6):507-16. PubMed ID: 22001954
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-converting enzyme inhibitor dosages in elderly patients with heart failure.
Chen YT; Wang Y; Radford MJ; Krumholz HM
Am Heart J; 2001 Mar; 141(3):410-7. PubMed ID: 11231438
[TBL] [Abstract][Full Text] [Related]
18. American College of Cardiology/American Heart Association Chronic Heart Failure Evaluation and Management guidelines: relevance to the geriatric practice.
Ahmed A
J Am Geriatr Soc; 2003 Jan; 51(1):123-6. PubMed ID: 12534856
[TBL] [Abstract][Full Text] [Related]
19. Use of angiotensin-converting enzyme inhibitors in patients with heart failure and renal insufficiency: how concerned should we be by the rise in serum creatinine?
Ahmed A
J Am Geriatr Soc; 2002 Jul; 50(7):1297-300. PubMed ID: 12133029
[TBL] [Abstract][Full Text] [Related]
20. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study.
Teng TK; Tromp J; Tay WT; Anand I; Ouwerkerk W; Chopra V; Wander GS; Yap JJ; MacDonald MR; Xu CF; Chia YM; Shimizu W; ; Richards AM; Voors A; Lam CS
Lancet Glob Health; 2018 Sep; 6(9):e1008-e1018. PubMed ID: 30103979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
